Welcome to LookChem.com Sign In|Join Free
  • or
(S)-Ethyl 4-benzyl-5-oxo-morpholine-3-carboxylate is a morpholine derivative with the molecular formula C16H19NO4. It is characterized by the presence of an ethyl ester group, a benzyl group, and a carboxylate group. This chemical compound has potential applications in medicinal chemistry and drug development due to its unique structural features and the presence of the morpholine ring, which is found in many biologically active compounds.

106973-40-4

Post Buying Request

106973-40-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

106973-40-4 Usage

Uses

Used in Medicinal Chemistry:
(S)-Ethyl 4-benzyl-5-oxo-morpholine-3-carboxylate is used as a building block in the synthesis of new pharmaceutical compounds. Its morpholine ring and functional groups, such as the ethyl ester and benzyl group, can be utilized to create novel molecules with potential therapeutic properties.
Used in Drug Development:
(S)-Ethyl 4-benzyl-5-oxo-morpholine-3-carboxylate is used as a starting material or intermediate in the development of new drugs. Its structural features can be modified to optimize pharmacological properties, such as potency, selectivity, and bioavailability, leading to the discovery of new therapeutic agents.
Used in Drug Design:
(S)-Ethyl 4-benzyl-5-oxo-morpholine-3-carboxylate is used as a template in the design of new drugs. Its unique structure can be further modified or combined with other chemical moieties to create new drug candidates with improved pharmacological profiles and therapeutic potential.
Further research may be warranted to determine the specific activities and potential therapeutic applications of (S)-ethyl 4-benzyl-5-oxo-morpholine-3-carboxylate, as its unique structural features and presence in biologically active compounds suggest a promising role in the field of medicinal chemistry and drug development.

Check Digit Verification of cas no

The CAS Registry Mumber 106973-40-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,6,9,7 and 3 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 106973-40:
(8*1)+(7*0)+(6*6)+(5*9)+(4*7)+(3*3)+(2*4)+(1*0)=134
134 % 10 = 4
So 106973-40-4 is a valid CAS Registry Number.
InChI:InChI=1/C14H17NO4/c1-2-19-14(17)12-9-18-10-13(16)15(12)8-11-6-4-3-5-7-11/h3-7,12H,2,8-10H2,1H3/t12-/m0/s1

106973-40-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name ethyl (3S)-4-benzyl-5-oxomorpholine-3-carboxylate

1.2 Other means of identification

Product number -
Other names ethyl (S)-5-oxo-4-(phenylmethyl)morpholine-3-carboxylate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:106973-40-4 SDS

106973-40-4Relevant academic research and scientific papers

Properties and Reactions of Substituted 1,2-Thiazetidine 1,1-Dioxides: Chiral Mono- and Bicyclic 1,2-Thiazetidine 1,1-Dioxides from α-Amino Acids

Meinzer, Alexandra,Breckel, Andrea,Thaher, Bassam Abu,Manicone, Nico,Otto, Hans-Hartwig

, p. 90 - 105 (2007/10/03)

New chiral mono- and bicyclic β-sultams, valuable building blocks for drug synthesis, have been prepared from L-Ala, L-Val, L-Leu, L-Ile, L-Phe, L-Cys, L-Ser, L-Thr, and D-penicillamine by transformation of the COOH group into a methylsulfonyl chloride function, followed by cyclization under basic conditions. Selected properties, derivatives, and reactions of the β-sultams are described.

Chiral Synthesis of 3-Substituted Morpholines via Serine Enantiomers and Reductions of 5-Oxomorpholine-3-carboxylates

Brown, George R.,Foubister, Alan J.,Wright, Brian

, p. 2577 - 2580 (2007/10/02)

The chiral synthesis of 3-hydroxymethyl- and 3-carboxy-morpholines from serine enantiomers is described.Chemoselective and total reductions of 5-oxomorpholine-3-carboxylates are key synthetic steps.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 106973-40-4